Agios Pharmaceuticals, Inc.
AGIO
Revenue
12.46M
▲3.73M▲42.73%
3 Months ChangeAssets
1.47B
▼-84.28M▼-5.42%
3 Months ChangeLiabilities
101.68M
▲12.69M▲14.26%
3 Months ChangeFree Cash Flow
-112.26M
▼-12.25M▼-12.25%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 10-Q
ID: 0001439222-24-000138
2024-10-31
Form 8-K
ID: 0001439222-24-000136
2024-08-01
Form 10-Q
ID: 0001439222-24-000121
2024-08-01
Form 8-K
ID: 0001439222-24-000117
2024-06-20
Form 8-K
ID: 0001193125-24-164555
2024-05-28
Form 8-K
ID: 0001193125-24-147583
2024-05-02
Form 10-Q
ID: 0001439222-24-000069
2024-05-02
Form 8-K
ID: 0001439222-24-000067
2024-02-15
Form 8-K
ID: 0001439222-24-000032
2024-01-08
Form 8-K
ID: 0001193125-24-003920